Your session is about to expire
← Back to Search
Speech Tasks for Speech Perception
N/A
Waitlist Available
Led By Edward F Chang, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Participants who lack capacity or decline to provide informed consent
Participants with cognitive deficits that preclude reliable completion of study tasks
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during procedure
Awards & highlights
No Placebo-Only Group
Summary
This trial is investigating how the brain extracts linguistic elements from speech sounds in order to better understand and treat human language disorders.
Who is the study for?
This trial is for individuals at UCSF with epilepsy or brain tumors who are undergoing surgical electrode implantation. They must have electrodes in at least two key brain areas and be able to perform study tasks. Those unable to consent, with significant cerebral lesions, or cognitive deficits that prevent task completion cannot participate.
What is being tested?
The study investigates how the superior temporal gyrus of the brain processes speech sounds. Participants will perform speech tasks while their brain activity is monitored to understand how we perceive words and continuous speech, aiming to improve language disorder treatments.
What are the potential side effects?
Since this trial involves non-invasive speech tasks without drugs or medical procedures beyond those already required for participants' clinical care, there are no direct side effects from the interventions being studied.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am unable or unwilling to give consent for this trial.
Select...
I am able to understand and complete study tasks despite any cognitive issues.
Select...
I have significant brain lesions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ during procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during procedure
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of Participants with Electrocorticography (ECoG) Signals for Neural Activity Identified During Intraoperative Procedure or Inpatient Hospitalization
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Electrocorticography (ECoG) recording during Speech TasksExperimental Treatment1 Intervention
Participants listened to 25-minute Speech Tasks while ECoG signals for neural activity was recorded during their intraoperative procedure or inpatient hospitalization at the University of California, San Francisco (UCSF).
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,583 Previous Clinical Trials
15,083,807 Total Patients Enrolled
2 Trials studying Speech
82 Patients Enrolled for Speech
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
352 Previous Clinical Trials
181,129 Total Patients Enrolled
15 Trials studying Speech
1,991 Patients Enrolled for Speech
University of California, BerkeleyOTHER
186 Previous Clinical Trials
640,688 Total Patients Enrolled
1 Trials studying Speech
52 Patients Enrolled for Speech
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am able to understand and complete study tasks despite any cognitive issues.I have electrodes implanted in my brain and can follow study instructions.I am unable or unwilling to give consent for this trial.I am undergoing surgery at UCSF for epilepsy or a brain tumor, involving electrode implantation or awake brain mapping.I have significant brain lesions.
Research Study Groups:
This trial has the following groups:- Group 1: Electrocorticography (ECoG) recording during Speech Tasks
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger